← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2009Last known activity
Nov 20, 2023
Timeline
1970s
- Jun 1, 1974
Hanlim Pharm. Co., Ltd.— Founded
Drugs by trial phase (31 distinct, 44 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Arthritis
- Arthritis, Rheumatoid
- Breast Diseases
- Bronchitis
- Bronchitis, Chronic
- Diabetic Retinopathy
- Dry Eye Syndromes
- Dyslipidemias
- Essential Hypertension
- Eye Diseases
- Glaucoma
- Hypercholesterolemia
- Hypertension
- Keratoconjunctivitis Sicca
- Lung Neoplasms
- Osteoarthritis
- Osteoarthritis, Knee
- Osteoporosis
- Pneumonia
- Pruritus
- Radiation Pneumonitis
- Retinal Diseases
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Urticaria
Recent trials (44)
- NCT06475872Lead sponsorPhase 1Nov 20, 2023
- NCT06642987Lead sponsorPhase 1Oct 23, 2023
- NCT05358080Lead sponsorPhase 4May 27, 2022
- NCT06038084CollaboratorPhase 4Apr 15, 2022
- NCT06078592CollaboratorPhase 4Oct 8, 2021
- NCT04882228Lead sponsorPhase 4Jan 28, 2021
- NCT04632342Lead sponsorPhase 2Nov 30, 2020
- NCT04638426Lead sponsorPhase 2Sep 10, 2020
- NCT04633733Lead sponsorPhase 1Aug 22, 2020
- NCT04606329Lead sponsorPhase 3Jul 20, 2020
- NCT04659070Lead sponsorPhase 3Jul 15, 2020
- NCT04667624Lead sponsorPhase 1Feb 29, 2020
- NCT04114461Lead sponsorPhase 1Nov 30, 2019
- NCT04647461CollaboratorPhase 4Mar 20, 2019
- NCT03896594Lead sponsorPhase 1Dec 24, 2018
Details
- Founded
- Seoul, KR Jun 1, 1974
- Last known activity
- Nov 20, 2023